Home Eric Rosenthal Reports

Eric Rosenthal Reports

Professional Societies Disclose Their Disclosure Policies, But Why Won’t Some Discuss...

Last month I wrote about “How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?” The article dealt with the fallout of Baselga’s...

Otis Brawley Discusses Life After Leaving the American Cancer Society

When Otis W. Brawley, MD — who had served as the face of the American Cancer Society (ACS) for the past 11 years—resigned earlier...

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s...

In the aftermath of the fall of renowned breast cancer researcher Jose Baselga, MD, PhD, following revelations last month of his failure to disclose...

How a Hollywood-and-Scientist Dream Team Created a New Paradigm in Collaborative...

This year marks the 10th anniversary of the launch of Stand Up To Cancer (SU2C)—an enterprise that was at its inception an innovative and...

Mike Caligiuri Discusses Upcoming AACR Meeting, Cancer Health Equality, and Sudden...

During last year’s American Association for Cancer Research (AACR) annual meeting in Washington, DC, the association’s president Michael A. Caligiuri, MD, discussed his presidential...

Why Academia Wasn’t Ready to Build Big Data Systems – A...

Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion. Roche...

Eric Rosenthal Reports | A Personal Remembrance of Two Giants of...

James F. Holland, MD, one of the pioneers of combination chemotherapy and cancer cooperative group research, died at the age of 92 on March...

Latest